Drug Shortage Report for LOESTRIN 1.5/30
| Report ID | 130392 |
| Drug Identification Number | 00353027 |
| Brand name | LOESTRIN 1.5/30 |
| Common or Proper name | Loestrin |
| Company Name | ALLERGAN INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | NORETHINDRONE ACETATE ETHINYL ESTRADIOL |
| Strength(s) | 1.5MG 30MCG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 5x28 |
| ATC code | G03AA |
| ATC description | HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-10-22 |
| Estimated end date | 2021-02-10 |
| Actual end date | 2021-01-22 |
| Shortage status | Resolved |
| Updated date | 2021-01-23 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2021-01-23 | English | Compare |
| v4 | 2021-01-22 | French | Compare |
| v3 | 2021-01-22 | English | Compare |
| v2 | 2020-12-18 | French | Compare |
| v1 | 2020-12-18 | English | Compare |
Showing 1 to 5 of 5